PBM Capital Group
19
60M
13
1.46
4
0.32
5
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Charlottesville.
The high activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The fund is generally included in 2-6 deals every year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Candel, Landos Biopharma, ArcherDX. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the PBM Capital Group, startups are often financed by The Peierls Foundation, Perceptive Advisors, National Securities Corporation. The meaningful sponsors for the fund in investment in the same round are Perceptive Advisors, Longwood Founders Fund, Boulder Ventures. In the next rounds fund is usually obtained by The Peierls Foundation, Sands Capital Ventures, Perceptive Advisors.
Investments analytics
Analytics
- Total investments
- 19
- Lead investments
- 4
- Exits
- 5
- Rounds per year
- 1.46
- Follow on index
- 0.32
- Investments by industry
- Biotechnology (18)
- Life Science (9)
- Therapeutics (8)
- Genetics (8)
- Health Care (6) Show 9 more
- Investments by region
-
- United States (18)
- United Kingdom (1)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 129M
- Group Appearance index
- 0.84
- Avg. company exit year
- 11
- Avg. multiplicator
- 4.62
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Candel | 04 Jan 2019 | Biotechnology, Health Care, Health Diagnostics, Genetics, Medical, Therapeutics | Early Stage Venture | 28M | United States, Massachusetts |
| AppBugs | 03 Feb 2016 | Software, Apps, Computer | Seed | 700K | United States, Washington, Redmond |
| Taysha Gene Therapies | 05 Aug 2020 | Biotechnology, Genetics, Life Science | Early Stage Venture | 95M | United States, Texas, Dallas |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.